Ethnicity and geographic distribution of pediatric chronic ataxia in Manitoba

Canadian Journal of Neurological Sciences

Volumn 41, Issue 1, 2014, Pages 29-36

  Salman, Michael S ^a   Masood, Shaheen ^a   Azad, Meghan ^b   Chodirker, Bernard N ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ARTICLE; ATAXIA; ATAXIA TELANGIECTASIA; CANADA; CHILD; CHRONIC DISEASE; DEVELOPMENTAL DISORDER; DISEASE ASSOCIATION; DISORDERS OF MITOCHONDRIAL FUNCTIONS; ETHNICITY; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; HUTTERITE; INDIGENOUS PEOPLE; JOUBERT SYNDROME; MAJOR CLINICAL STUDY; MALE; MENNONITE; NEURONAL MIGRATION DISORDER; PREVALENCE; PYRAMIDAL SIGN; ADULT; ETHNIC GROUP; ETHNOLOGY; FACTUAL DATABASE; INFANT; MANITOBA; PRESCHOOL CHILD; RISK FACTOR; YOUNG ADULT;

ADOLESCENT; ADULT; ATAXIA; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DATABASES, FACTUAL; ETHNIC GROUPS; FEMALE; HUMANS; INFANT; MALE; MANITOBA; RISK FACTORS; YOUNG ADULT;

EID: 84908272469     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S031716710001622X     Document Type: Article

References (22)

1. Sequeiros J, Martins S, Silveira I. Epidemiology and population genetics of degenerative ataxias. Handb Clin Neurol. 2012;103: 227-51.
2. Werdelin L, Keiding N. Hereditary ataxias: epidemiological aspects. Neuroepidemiology. 1990;9(6):321-31.
3. Collins SA, Sinclair G, McIntosh S, et al. Carnitine palmitoyltransferase 1A (CPT1A) P479L prevalence in live newborns in Yukon, Northwest Territories, and Nunavut. Mol Genet Metab. 2010;101(2-3):200-4.
4. Greenberg CR, Dilling LA, Thompson GR, et al. The paradox of the carnitine palmitoyltransferase type Ia P479L variant in Canadian Aboriginal populations. Mol Genet Metab. 2009;96 (4):201-7.
5. Morton DH, Morton CS, Strauss KA, et al. Pediatric medicine and the genetic disorders of the Amish and Mennonite people of Pennsylvania. Am J Med Genet C Semin Med Genet. 2003;121C (1):5-17.
6. Thomson AK, Glasson EJ, Bittles AH. A long-term populationbased clinical and morbidity profile of Angelman syndrome in Western Australia: 1953-2003. Disabil Rehabil. 2006;28(5): 299-305.
7. Tsuji S, Onodera O, Goto J, Nishizawa M, on behalf of the study group on ataxic diseases. Sporadic ataxias in Japan-a population-based epidemiological study. Cerebellum. 2008;7(2): 189-97.
8. Palau F, Espinós C. Autosomal recessive cerebellar ataxias. Orphanet J Rare Dis. 2006;1:47.
9. Erichsen AK, Koht J, Stray-Pedersen A, Abdelnoor M, Tallaksen CME. Prevalence of hereditary ataxia and spastic paraplegia in southeast Norway: a population-based study. Brain. 2009;132(Pt 6):1577-88.
10. Anheim M, Fleury M, Monga B, et al. Epidemiological, clinical, paraclinical and molecular study of a cohort of 102 patients affected with autosomal recessive progressive cerebellar ataxia from Alsace, Eastern France: implications for clinical management. Neurogenetics. 2010;11(1):1-12.
11. Sridharan R, Radhakrishnan K, Ashok PP, Mousa ME. Prevalence and pattern of spinocerebellar degenerations in northeastern Libya. Brain. 1985;108( Pt 4):831-43.
12. Boycott KM, Flavelle S, Bureau A, et al. Homozygous deletion of the very low density lipoprotein receptor gene causes autosomal recessive cerebellar hypoplasia with cerebral gyral simplification. Am J Hum Genet. 2005;77(3):477-83.
13. Dupré N, Bouchard JP, Brais B, Rouleau GA. Hereditary ataxia, spastic paraparesis and neuropathy in the French-Canadian population. Can J Neurol Sci. 2006;33(2):149-57.
14. Salman MS, Lee EJ, Tjahjadi A, Chodirker BN. The epidemiology of intermittent and chronic ataxia in children in Manitoba, Canada. Dev Med Child Neurol. 2013;55(4):341-7.
15. Statistics Canada, 2001 Census of population of Canada, provinces, territories (data products, topic-based tabulations) catalogues no. 95F0300XCB2001004, 97F0022XCB2001002, 97F0011XCB 2001002, 95F0363XCB2001003 (Manitoba, Code 46). Ottawa, Ontario: Statistics Canada. Available from: http://www12. statcan.ca/english/census01/products/standard/themes/indexeng. cfm (accessed December 24th 2012).
16. Buckley RH, Dinno N, Weber P. Angelman syndrome: are the estimates too low? Am J Med Genet. 1998;80(4):385-90.
17. Orton NC, Innes AM, Chudley AE, Bech-Hansen NT. Unique disease heritage of the Dutch-German Mennonite population. Am J Med Genet A. 2008;146A(8):1072-87.
18. Telatar M, Teraoka S, Wang Z, et al. Ataxia-Telangiectasia: identification and detection of founder-effect Mutations in the ATM gene in ethnic populations. Am J Hum Genet. 1998;62: 86-97.
19. Labuda M, Labuda D, Miranda C, et al. Unique origin and specific ethnic distribution of the Friedreich ataxia GAA expansion. Neurology. 2000;54(12):2322-4.
20. Moore SJ, Buckley DJ, MacMillan A, et al. The clinical and genetic epidemiology of neuronal ceroid lipofuscinosis in Newfoundland. Clin Genet. 2008;74:213-22.
21. VAMP1 mutation causes dominant hereditary spastic ataxia in Newfoundland families. Bourassa CV, Meijer IA, Merner ND, et al. Am J Hum Genet. 2012;91(3):548-52.
22. Boycott KM, Parboosingh JS, Scott JN, et al. Meckel syndrome in the Hutterite population is actually a Joubert-related cerebellooculo-renal syndrome. Am J Med Genet A. 2007;143A(15): 1715-25.